NEAL KLEIMAN to Coronary Thrombosis
This is a "connection" page, showing publications NEAL KLEIMAN has written about Coronary Thrombosis.
Connection Strength
1.246
-
Platelet pathophysiology, pharmacology, and function in coronary artery disease. Coron Artery Dis. 2017 Nov; 28(7):614-623.
Score: 0.612
-
Balancing hemostasis and thrombosis in interventional vascular medicine and surgery. Methodist Debakey Cardiovasc J. 2011 Oct-Dec; 7(4):19-23.
Score: 0.402
-
Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv. 2010 Sep; 3(9):920-7.
Score: 0.093
-
Therapeutic use of intravenous eptifibatide in patients undergoing percutaneous coronary intervention: acute coronary syndromes and elective stenting. Am J Cardiovasc Drugs. 2004; 4(1):31-41.
Score: 0.059
-
Bioresorbable Scaffold: The Emerging Reality and Future Directions. Circ Res. 2017 Apr 14; 120(8):1341-1352.
Score: 0.037
-
Intravenous platelet blockade with cangrelor during PCI. N Engl J Med. 2009 Dec 10; 361(24):2330-41.
Score: 0.022
-
Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry. Catheter Cardiovasc Interv. 2009 Jun 01; 73(7):874-80.
Score: 0.021